What is the share price of CCME Global Ltd (CCME) today?
The share price of CCME as on 15th September 2026 is ₹31.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on CCME Global Ltd (CCME) share?
The past returns of CCME Global Ltd (CCME) share are- Past 1 week: 13.23%
- Past 1 month: -49.76%
- Past 3 months: -67.84%
- Past 6 months: -68.18%
- Past 1 year: -38.17%
- Past 3 years: 180.25%
- Past 5 years: 303.33%
What are the peers or stocks similar to CCME Global Ltd (CCME)?
The peers or stocks similar to CCME Global Ltd (CCME) include:What is the market cap of CCME Global Ltd (CCME) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of CCME Global Ltd (CCME) is ₹39 Cr as of 15th September 2026.What is the 52 week high and low of CCME Global Ltd (CCME) share?
The 52-week high of CCME Global Ltd (CCME) is ₹184.90 and the 52-week low is ₹26.41.What is the PE and PB ratio of CCME Global Ltd (CCME) stock?
The P/E (price-to-earnings) ratio of CCME Global Ltd (CCME) is -54.93. The P/B (price-to-book) ratio is 0.97.Which sector does CCME Global Ltd (CCME) belong to?
CCME Global Ltd (CCME) belongs to the Health Care sector & Biotechnology sub-sector.How to buy CCME Global Ltd (CCME) shares?
You can directly buy CCME Global Ltd (CCME) shares on Tickertape. Simply sign up, connect your demat account and place your order.
CCME Global Ltd
CCME Share Price
BSECCME Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CCME Performance & Key Metrics
CCME Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -45.88 | 0.97 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.99 | 5.89 | 0.48% |
CCME Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
CCME Company Profile
Genesis IBRC India Ltd is a biotechnology company focused on developing and marketing microbial and antimicrobial products for aquaculture, agriculture, poultry, and animal husbandry sectors.
CCME Forecast
CCME Forecasts
CCME
CCME
Income
Balance Sheet
Cash Flow
CCME Income Statement
CCME Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 3.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | ||||||||||
| Operating & Other expenses | 3.69 | 0.10 | 0.02 | 0.03 | 0.02 | 0.12 | 0.06 | 0.03 | 0.54 | 0.24 | ||||||||||
| EBITDA | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.24 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | ||||||||||
| PBIT | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.26 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.26 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.26 | ||||||||||
| EPS | -2.84 | -0.07 | 2.81 | -0.02 | -0.02 | -0.09 | -0.05 | -0.02 | -0.37 | -0.06 |
CCME Company Updates
CCME Stock Peers
CCME Past Performance & Peer Comparison
CCME Past Performance & Peer Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| CCME Global Ltd | -54.93 | 0.97 | — |
| Biocon Limited | 165.02 | 1.74 | 0.13% |
| Anthem Biosciences Limited | 89.55 | 17.42 | 0.21% |
| Sai Life Sciences Limited | 96.49 | 13.55 | — |
CCME Stock Price Comparison
Compare CCME with any stock or ETFCCME Holdings
CCME Shareholdings
CCME Promoter Holdings Trend
CCME Promoter Holdings Trend
CCME Institutional Holdings Trend
CCME Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 2.60%
In last 3 months, foreign institutional holding of the company has almost stayed constant
CCME Shareholding Pattern
CCME Shareholding Pattern
CCME Shareholding History
CCME Shareholding History
smallcases containing CCME stock
smallcases containing CCME stock
Looks like this stock is not in any smallcase yet.
CCME Events
CCME Events
CCME Dividend Trend
CCME has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
CCME Dividend Trend
CCME has not given any dividends in last 5 years
CCME Dividends
CCME Dividends
CCME Stock News & Opinions
CCME Stock News & Opinions
CCME Global Limited, formerly known as Genesis IBRC India Limited, will close its Register of Members and Share Transfer Books from Wednesday, September 23, 2026, to Tuesday, September 29, 2026, for its 34th Annual General Meeting scheduled for Tuesday, September 29, 2026, at 3:00 p.m. (IST).
CCME Global Limited, formerly Genesis IBRC India Limited, is undertaking a series of corporate actions including acquisitions and a stock split, as detailed in a regulatory filing as of August 29, 2026. The company plans to acquire 100% of CCME UAE and 52% of Interlink, issuing a total of 19,63,17,249 shares with a face value of INR 10 each for these acquisitions, based on valuations from an Independent Registered Valuer and a Category I Merchant Banker. Additionally, CCME Global Limited intends to execute a 1:10 stock split, reducing the face value of each share from INR 10 to INR 1, aiming to enhance liquidity and broaden accessibility for smaller investors, with completion expected during fiscal year 2026-2027. The company’s authorized, issued, and paid-up share capital will be impacted by the split, but no shareholders were left without shares. Managing Director Poonam Chaturvedi oversees these changes.
CCME Global Limited, formerly Genesis IBRC India Limited, has undertaken significant corporate actions including preferential allotments of shares to facilitate the acquisition of Interlink Distribution LLC and related entities, with shareholders such as Mr. Mostafa Ahmed Kabir and Mr. Poonam Chaturvedi participating. The company is also planning a 1:10 stock split, reducing the face value of each share from INR 10 to INR 1, intended to enhance liquidity and broaden accessibility for smaller investors, with completion anticipated within the fiscal year 2026-2027. These moves, approved by the Board of Directors and compliant with SEBI regulations, reflect a period of substantial growth for the company, as demonstrated by the considerable number of shares issued and a consistent paid-up capital of INR 196,31,72,490 both before and after the planned split.
CCME Global Limited, formerly Genesis IBRC India Limited, has completed a preferential allotment of shares to facilitate the acquisitions of CCME UAE and Interlink Distribution LLC, and approved a 1:10 stock split intended to enhance liquidity and broaden investor accessibility. The company allotted 19,63,17,249 shares to Mr. Mostafa Ahmed Kabir, who holds a 52% stake in Interlink Distribution LLC, receiving 2,03,42,249 shares in exchange. The stock split will reduce the face value of equity shares from INR 10 to INR 1 and is expected to be completed during the current fiscal year. Managing Director Poonam Chaturvedi oversaw the transactions, which were valued by an Independent Registered Valuer and a Category I Merchant Banker, and represent a filing required for regulatory compliance.
CCME Global Limited, formerly Genesis IBRC India Limited, announced preferential allotments of shares to acquire 52% stakes in CCME UAE and Interlink, alongside acquisitions of other entities involving Managing Director Poonam Chaturvedi and others. The company’s authorized share capital is INR 200 crore, with an issued and subscribed share capital of INR 196.32 crore and a paid-up share capital of the same amount, comprising 19.63 crore shares with a face value of INR 10 each. To enhance liquidity and broaden investor accessibility, CCME Global Limited plans a 1:10 stock split within the current fiscal year, which will increase the number of equity shares to 196.32 crore with a face value of INR 1 per share. The acquisitions and stock split are being formally disclosed in compliance with Securities and Exchange Board of India (SEBI) regulations.
CCME Global Limited, formerly Genesis IBRC India Limited, is undertaking several capital structure changes, including acquisitions and a stock split expected to be completed in the current fiscal year 2026-2027. The company has allotted shares to acquire 52% of Interlink Distribution LLC and a corresponding stake held by Mostafa Ahmed Kabir, for a total value of INR 196,31,72,490. Separately, CCME Global Limited plans a 1:10 stock split, reducing the face value per share from INR 10 to INR 1 to enhance liquidity and broaden investor participation. Following the split, the authorized, issued, subscribed, and paid-up share capital will remain at 20,00,00,000 shares with a total value of INR 200,00,00,000. Poonam Chaturvedi serves as Managing Director of CCME Global Limited.
CCME Global Limited, formerly known as Genesis IBRC India Limited, will hold a board meeting on August 29, 2026, to consider matters including an increase in the company’s authorized share capital and alteration of its memorandum of association, evaluating a potential fundraising through equity shares or other eligible securities, sub-division of share capital, approval of the Directors Report for the financial year ended March 31, 2026, acquisition of entities, a shift in the registered office, and the convening of the Annual General Meeting.
CCME Global Limited, formerly known as Genesis IBRC India Limited, informed the Bombay Stock Exchange on August 18, 2026, of the death of Independent Non-Executive Director Ashok Chhaganbhai Patel, whose death occurred on August 15, 2026.
CCME Global Limited, formerly known as Genesis IBRC India Limited, announced that its board approved the unaudited financial results for the first quarter ending June 30, 2026, along with a limited review report, and appointed M/s G J M S & Associates LLP as internal auditors for the fiscal year 2026-2027. The company also reported that there was no deviation in the utilization of Rs 32.25 crore raised through a preferential issue in March 2026, which was allocated to expanding its FMCG and commodities business, working capital for its import & export business, strategic investments, and general corporate purposes.
CCME Global Limited, formerly known as Genesis IBRC India Limited, will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results along with the limited review report for the first quarter ending June 30, 2026, according to a regulatory filing. The company’s trading window for securities will remain closed until 48 hours after the declaration of the unaudited standalone financial results.
In last 6 months, promoter holding in the company has increased by 63.02%
Pledged promoter holdings is insignificant